| Research group -
Publications |
|
| News (in German) Curriculum vitae Teaching Publications and Posters My research interests Our research group Information for students (in German) Table soccer Contact Links |
Recent publications could be found via this link: AIT publication data base Selected full papers and book contributions: 1.R. Bauer, R. Lauer, B. Linz, F. Pittner, G.A. Peschek, G.F. Ecker, P. Friedl, C.R. Noe:"An in vitro model for blood brain barrier permeation", Sci. Pharm. 70: 317-324 (2002). 2.R. Lauer, R. Bauer, B. Linz, F. Pittner, G. Peschek, G. Ecker, P. Friedl, C. R. Noe:"Development of an in vitro blood brain barrier model based on immortalized porcine brain microvascular endothelial cells", Farmaco 59: 133-137 (2004). 3.G.F. Ecker, C.R. Noe:"In silico prediction models for blood-brain barrier permeation", Curr. Med. Chem. 11: 1617-1628 (2004). 4.W. Neuhaus, J. Trzeciak, R. Lauer, B. Lachmann, C.R. Noe:"APTS-labeled dextrans: A novel tool for characterization of cell layer tightness" , J Pharm. Biomed. Anal. Vol 40 Issue 4, 1035-1039 (2006). 5.W. Neuhaus, E. Bogner, M. Wirth, J. Trzeciak, B. Lachmann, F. Gabor, C.R. Noe:"A novel tool to characterize paracellular transport: The APTS-dextran ladder", Pharm. Res., Vol 23 Issue 7, 1491-1501 (2006). 6.W. Neuhaus, R. Lauer, S. Oelzant, U.P. Fringeli, G.F. Ecker, C.R. Noe:"A novel flow based hollow-fiber blood-brain barrier in vitro model with immortalised cell line PBMEC/C1-2", J Biotechnol. Vol 125 Issue 1, 127-141 (2006). 7. B. Germann, W. Neuhaus, R. Hofer-Warbinek, C.R. Noe: „Applying blood-brain barrier in vitro models to study the influence of drugs on endothelial cells – effects of selected COX-inhibitors.“ Pharmazie Vol 63 Issue 4, 303-307 (2008). 8. W. Neuhaus, V.E. Plattner, M. Wirth, B. Germann, B. Lachmann, F. Gabor, C.R. Noe:"Validation of in vitro cell culture models of the blood-brain barrier: Tightness characterization of two promising cell lines", J. Pharm. Sci. Vol 97, 5158-5175 (2008). 9. W. Neuhaus, G. Trauner, D. Gruber, S. Oelzant, W. Klepal, B. Kopp, C.R. Noe: "Transport of a GABAA-receptor modulator and its derivatives derived from Valeriana officinalis L. s.l. across an in vitro cell culture model of the blood-brain barrier" Planta Med. Vol 74, 1338-1344 (2008). 10. W. Neuhaus, M. Wirth, V.E. Plattner, B. Germann, F. Gabor, C.R. Noe: "Expression of Claudin-1, Claudin-3 and Claudin-5 in human blood-brain barrier mimicking cell line ECV304 is inducible by glioma conditioned media", Neurosci. Lett. Vol 446 Issues 2-3, 59-64 (2008). 11. W. Neuhaus, B. Germann, V.E. Plattner, M. Wirth, F. Gabor, C.R. Noe:"Alteration of the glycocalyx of two blood-brain barrier mimicking cell lines is inducible by glioma conditioned media", Brain Res. Vol 1279, 82-89 (2009). 12. W. Neuhaus, C.R. Noe: "Transport at the Blood-Brain Barrier", In: Transporters as drug carriers, G.F. Ecker, P. Chiba (eds.), Whiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, pages 263-298 (2009). 13. B. Bennani-Baiti, C.R. Noe: "Drug Transporters in Health and Disease", In: Transporters as drug carriers, G.F. Ecker, P. Chiba (eds.), Whiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, pages 387-416 (2009). 14. V. Poetsch, B. Bennani-Baiti, W. Neuhaus, E.-M. Muchitsch, C.R. Noe:"Serum-derived Immunoglobulins alter Amyloid-β transport across a blood-brain barrier in vitro model", Pharmazie 65, 267-273 (2010). 15. V.E. Plattner, B. Germann, W. Neuhaus, C.R. Noe, F. Gabor, M. Wirth:"Characterization of two blood-brain barrier mimicking cell lines: distribution of lectin binding sites and perspectives for drug delivery", Int. J. Pharm. Vol 387, 34-41 (2010). 16. W. Neuhaus, M. Stessl, E. Strizsik, B. Bennani-Baiti, M. Wirth, S. Toegel, M. Modha, J. Winkler, F. Gabor, H. Viernstein, C.R. Noe:"Blood-Brain Barrier Cell Line PBMEC/C1-2 possesses functionally active P-glycoprotein", Neurosci. Lett. 469, 224-228 (2010). 17. V. Poetsch, W. Neuhaus, C.R. Noe:"Serum-derived Immunoglobulins neutralize adverse effects of amyloid β peptide on the integrity of a blood-brain barrier in vitro model", J. Alzheimers Dis. 21, 303-314 (2010). 18. W. Bueter, N.R. Saunders, C. Mallard, H.-C. Bauer, H.B. Stolp, A. Kavelaars, O. Dammann, NEUROBID consortium: "NEUROBID-an EU-funded project to study the developing brain barriers", Int. Dev. Neurosci. 28, 411-412 (2010). 19. W. Neuhaus, M. Freidl, P. Szkokan, M. Berger, M. Wirth, J. Winkler, F. Gabor, C. Pifl, C.R. Noe:"Effects of NMDA-receptor modulators on a blood-brain barrier in vitro model", Brain Res. 1394, 49-61 (2011). 20.W. Neuhaus, M.A. Schick, R.R Bruno, B. Schneiker, C. Foerster, N. Roewer, C. Wunder:"The effects of colloid solutions on renal proximal tubular cells in vitro", Anesthesia & Analgesia 114, 371-374 (2012). 21. W. Neuhaus, M. Burek, C. Wunder, C.Y. Förster: "Novel strategies to restore blood-brain barrier integrity after brain injury", In: Blood Brain Barrier: New Research, P.A. Montenegro, S.M. Juárez (eds.), Nova Science, 1st Edition, Hauppauge NY, chaper 5, ISBN 978-1-62100-766-1, pages 145-172 (2012). 22. W. Neuhaus, M. Burek, C.S. Djuzenova, S. Thal, H. Koepsell, N. Roewer, C. Foerster:"Addition of NMDA-receptor antagonist MK801 during oxygen/glucose deprivation moderately attenuates the up-regulation of glucose uptake after subsequent reoxygenation in brain endothelial cells", Neurosci. Lett. 506, 44-49 (2012). 23. W. Neuhaus, J. Mandikova, R. Pawlowitsch, B. Linz, B. Bennani-Baiti, R. Lauer, B. Lachmann, C.R. Noe:"Blood-brain barrier in vitro models as tools in drug discovery: Assessment of the transport ranking of antihistaminic drugs", Pharmazie 67, 432-439 (2012). 24. W. Neuhaus, F. Samwer, S. Kunzmann, R.M. Muellenbach, M. Wirth, C.P. Speer, N. Roewer, C.Y. Förster:"Lung endothelial cells strengthen, but brain endothelial cells weaken barrier properties of a human alveolar epithelium cell culture model", Differentiation 84, 294-304 (2012). 25. S. Shityakov, W. Neuhaus, T. Dandekar, C. Förster:"Analyzing molecular polar surface descriptors to predict blood-brain barrier permeation", Int. J. Comp. Biol. Drug Design 6, 146-156 (2013). 26. S.C. Thal, E.-V. Schaible, W. Neuhaus, D. Scheffer, M. Brandstetter, K. Engelhard, C. Wunder, C.Y. Förster:"Inhibition of protesomal glucocorticoid receptor degradation restores dexamethasone-mediated stabilization of the blood-brain-barrier after traumatic brain injury", Crit. Care Med. 41, 1305-1315 (2013). 27. E. Salvador, W. Neuhaus, C.Y. Förster:"In vitro traumatic brain injury model through stretch injury using brain microvascular endothelial cells", J. Vis. Exp. 26;(80) (2013). 28. I. Novakova, E.-A. Subileau, S. Toegel, D. Gruber, B. Lachmann, E. Urban, C. Chesne, C.R. Noe, W. Neuhaus:"Transport rankings of non-steroidal antiinflammatory drugs across blood-brain barrier in vitro models", PLoS ONE 9(1):e86806 (2014). 29. RR. Bruno, W. Neuhaus, N. Roewer, C. Wunder, M.A. Schick:"Molecular size and origin do not influence the harmful side effects of hydroxyethylstarch on human proximal tubule cells (HK-2) in vitro", Anesthesia & Analgesia 119, 570-577 (2014). 30.
W.
Neuhaus, F. Gaiser, A. Mahringer, J. Franz, C.
Riethmüller, C.
Förster:"The pivotal role of astrocytes in an in-vitro
stroke
model of the blood-brain barrier", Frontiers of Cellular
Neuroscience
28;8:352 (2014). 31. S.C. Thal, W. Neuhaus: “The Blood-brain barrier as a target in traumatic brain injury treatment”, invited review in the Special Issue: The Blood-brain barrier in neurological diseases, Arch. Med. Res. 45(8), 698-710 (2014). 32.
J.
Wollborn, C. Wunder, J. Stix, W. Neuhaus,
R. Bruno, S. Flemming, N. Roewer,
N. Schlegel, M.A. Schick:"Phosphodiesterase-4-inhibition
with Rolipram attenuates hepatocellular injury in
hyperinflammation in
vivo and in vitro without influencing inflammation and
HO-1
expression", J.
Pharmacol. Pharmacother. 6 (1), 13-23 (2015). 33.
A.
Avdeef, M.A. Deli, W. Neuhaus:
“In-vitro assays for assessing BBB permeability:
artificial membrane
and cell culture models“, In: Li, Kerns (eds.),
Blood-Brain
Barrier in
Drug Discovery: Optimizing Brain Exposure of CNS Drugs
and Minimizing
Brain Side Effects, Wiley-VCH, chapter
10,
pages 188-237 (2015). 34.
W.
Neuhaus, M. Schlundt, M. Fehrholz, A.
Ehrke,
S. Kunzmann, S. Liebner, C.P. Speer, C.Y.
Förster:"Multiple antenatal dexamethasone treatment alters
brain
vessel differentation in newborn mouse pups", PLoS ONE
10(8): e0136221
(2015). 35.
M.A. Schick, W.
Baar, R.R. Bruno, J. Wollborn, C. Held, R. Schneider, S.
Flemming, N.
Schlegel,
N. Roewer,W. Neuhaus,
C. Wunder:"Balanced
hydroxyethylstarch (HES
130/0.4) impairs kidney function in-vivo without
inflammation",
PLoS
ONE 10 (9): e0137247 (2015). 36. S.R. Saroja,
Y.D. Aher, P. Kalaba, N.Y. Aher, M. Zehl, V. Korz, S.
Subramaniyan,
A.G. Miklosi, L. Zanon, W. Neuhaus, H.
Höger, T.
Langer, E. Urban, J. Leban, G.A. Lubec.
A
novel heterocyclic compound targeting the dopamine
transporter
improves performance in the radial arm maze and
modulates dopamine
receptors D1-D3. Behav Brain Res.
312:127-37 (2016).
Conference contributions: 1.R. Bauer, R. Lauer, B. Linz, G. Ecker, P. Friedl, C.R. Noe:"Development of an in vitro blood-brain barrier model based on immortalized porcine PBMEC/C1-2 cells", posterpresentation on the 6th Eurpean Congress of Pharmaceutical Sciences, EUFEPS 2000, Budapest, Sept. 2000; Abstract in: Eur. J. Pharm. Sci. 11/Suppl. 1: S105 (PO-219), 2000 2.R. Lauer, G. Jost, G.F. Ecker, C.R. Noe:"Optimierung eines in vitro Blut-Hirn-Schranken Modells", posterpresentation on the 16th Scientific Congress of the Austrian Pharmaceutical Society, Vienna 2001; Abstract in: Sci. Pharm. 69 (Suppl. 1), S89 (2001). 3.B. Linz, G. Ecker, C.R. Noe:"pH-metrische Bestimmung der logP-Werte von H1-Antihistaminika", posterpresentation on the Analytika 2002, Munich 2002 4.D. Niepel, T. Pöhler, M.L. Berger, G. Ecker, C.R. Noe:"Polyaminamide-derivatives with different pharmacological effects at the NMDA receptor as tools in drug research", posterpresentation at the 7th European Congress of Pharmaceutical Sciences, Stockholm 2002; Abstract in: Eur. J. Pharm. Sci. 17 (Suppl. 1), S81 (2002). 5.G. Ecker, C. Gallhuber, R. Lauer, C.R. Noe:"Artificial membrane permeation of a series of benzodiazepines", posterpresentation at the 7th European Congress of Pharmaceutical Sciences, Stockholm 2002; Abstract in: Eur. J. Pharm. Sci. 17 (Suppl. 1), S100 (2002). 6.R. Lauer, B. Dampier, G. Ecker, C.R. Noe:"The excitatory amino acid transport system EAAT2 and EAAT3 of an in vitro model of the blood brain barrier", posterpresentation at the 7th European Congress of Pharmaceutical Sciences, Stockholm 2002; Abstract in: Eur. J. Pharm. Sci. 17 (Suppl. 1), S113 (2002). 7.R. Lauer, G. Ecker, C.R. Noe:"Permeation of a set of benzodiazepines across an in vitro blood-brain barrier model", posterpresentation at the 7th European Congress of Pharmaceutical Sciences, Stockholm 2002; Abstract in: Eur. J. Pharm. Sci. 17 (Suppl. 1), S114 (2002). 8.J. Kainz, R. Lauer, W. Neuhaus, C.R. Noe, G.F. Ecker:"Physikochemische Charakterisierung einer Reihe von Glycinantagonisten zur Abschätzung ihrer Permeationseigenschaften in der Blut-Hirn Schranke", posterpresentation on the 17th Scientific Congress of the Austrian Pharmaceutical Society, Graz 2003; Abstract in: Sci. Pharm. 71, S57 (2003). 9.R. Lauer, J. Kainz, G.F. Ecker, C.R. Noe:"Anwendung eines in vitro Modells der Blut-Hirn Schranke: Transportstudien mit nichtsteroidalen Antirheumatika", posterpresentation on the 17th Scientific Congress of the Austrian Pharmaceutical Society, Graz 2003; Abstract in: Sci. Pharm. 71, S59 (2003). 10.T. Mayrhofer, W. Neuhaus, R. Lauer, G.F. Ecker, C.R. Noe:"Permeationsstudien einer Reihe von Glycin-Antagonisten an einem in vitro Modell der Blut-Hirn Schranke", posterpresentation on the 17th Scientific Congress of the Austrian Pharmaceutical Society, Graz 2003; Abstract in: Sci. Pharm. 71, S60 (2003). 11.W. Neuhaus, R. Lauer, G.F. Ecker, C.R. Noe:"Ein dynamisches in vitro Modell der Blut-Hirn Schranke", posterpresentation on the 17th Scientific Congress of the Austrian Pharmaceutical Society, Graz 2003; Abstract in: Sci. Pharm. 71, S61 (2003). 12.W. Neuhaus, J. Trzeciak, R. Lauer, B. Lachmann, C.R. Noe:"Tightness Determination of two Blood-Brain Barrier Models: Correction by means of Capillary gel electrophoresis", posterpresentation on the Analytica 2004 conference, Munich 2004, Abstract in: http://va.gdch.de/wwwdata/abstracts/5553/5553_0178.pdf 13.R. Pawlowitsch, W. Neuhaus, R. Lauer, B. Linz, B. Lachmann, G. F. Ecker, C. R. Noe:"Permeation studies of a set of antihistamines with an in vitro blood-brain barrier model", posterpresentation on the EuFEPS 2004 Meeting, Brussels, Abstract in: European Journal of pharmaceutical sciences, Volume 23, supplement 1, October 2004. 14.W. Neuhaus, J. Trzeciak, B. Lachmann, C.R. Noe:"APTS-labeled dextrans: A new tool for characterizing cell layer's tightness", posterpresentation on "Peripheral markers of Blood-brain barrier failure III symposium", Cleveland (Ohio, USA) November 2004, Abstract in: Syllabus (2004). 15.W. Neuhaus, E. Bogner, M. Wirth, B. Lachmann, F. Gabor, C.R. Noe:"The APTS-dextran ladder: A novel tool to determine the tightness status of cell layers",posterpresentation on the 19th Scientific Congress of the Austrian Pharmaceutical Society, Innsbruck 2006; Abstract in: Sci. Pharm. 74 (2), S47 (2006). 16. W. Neuhaus, R. Lauer, S. Oelzant, U.P. Fringeli, G.F. Ecker, C.R. Noe:"A flow based hollow-fiber blood-brain barrier in vitro model with immortalised cell line PBMEC/C1-2", posterpresentation at the Gordon Research Conference "Barries of the CNS", Tilton School, Tilton (NH, USA), June 25-30, 2006. 17. W. Neuhaus, V.E. Plattner, M. Wirth, B. Germann, B. Lachmann, F. Gabor, C.R. Noe:"Tightness characterisation of a blood-brain barrier in vitro model based on human cell line ECV304", posterpresentation on the 3rd Pharmaceutical Sciences World Congress, Amsterdam 22nd-25th April 2007. 18. W. Neuhaus, V.E. Plattner, M. Wirth, B. Germann, B. Lachmann, F. Gabor, C.R. Noe:"Tightness characterisation of a blood-brain barrier in vitro model based on human cell line ECV304", posterpresentation on the Pre-Satellite Meeting PhD and Post docs of the PSWC, Amsterdam 20th-21st April 2007. 19. G. Trauner, W. Neuhaus, C.R. Noe, B. Kopp:"The transport of GABAA-receptor modulators derived from Valeriana officinalis L", posterpresentation on the International Congress and 55th Annual Meeting of the Society for Medicinal Plant Research in Graz, Austria, 2nd-6th September 2007. 20. B.Germann, M. Wirth, C.R. Noe:"Einfluss von Gemcitabin und Cisplatin auf Endothelzellen in Blut-Hirn Schranken in vitro Modellen", posterpresentation on the DPHG-Tagung, Erlangen, Germany, 10th-13th October 2007. 21. B. Cohrs and M. Bethke, W. Neuhaus, B. Lachmann, C.R. Noe, B. Clement:"Transport of Pentamidine, Diminazene and derivatives across a blood-brain barrier in vitro model", posterpresentation on the DPHG-symposium 2007, Erlangen, Germany, 10th-13th October 2007. 22. V.E. Plattner, W. Neuhaus, B. Germann, F. Gabor, C.R. Noe, Michael Wirth:"Characterization of two blood-brain barrier in vitro models: distribution of lectin binding sites and perspectives for drug delivery", posterpresentation on the 7th Conference and Workshop on Biological Barriers and Nanomedicine - Advanced Drug Delivery and Predictive non vivo Testing Technologies, University of Saarland, Saarbrücken, Germany, 20th-29th February 2008. 23. V.E. Plattner, B. Germann, W. Neuhaus, F. Gabor, C.R. Noe, M. Wirth:"Lectin-mediated delivery at the blood-brain barrier: Evaluation of the lectin binding pattern of two blood-brain barrier in vitro models " posterpresentation at the 6th PBP World Meeting, Barcelona, Spain, 7th-10th April 2008. 24. W. Neuhaus, B. Germann, V.E. Plattner, F. Gabor, M. Wirth, C.R. Noe:"Glioma conditioned media cause alterations of lectin-binding capacities of two blood-brain barrier mimicking cell lines", posterpresentation at the Gordon Research Conference "Barries of the CNS", Tilton School, Tilton (NH, USA), 22nd-27th June 2008. 25. I. Novakova, W.Neuhaus, M. Sonnenberg, C.R. Noe:"Transport of NSAIDs across the Blood-Brain Barrier in vitro", posterpresentation on the 21th Scientific Congress of the Austrian Pharmaceutical Society, Vienna, Austria, 16th-18th April 2009; Abstract in: Sci. Pharm. 77 (1), PO-21 (2009) (http://www.scipharm.at/download.asp?id=452). 26. M. Freidl, W.Neuhaus, M. Wirth, F. Gabor, C.R. Noe:"Functionability of NMDA-Receptors in an in vitro model of the Blood-Brain-Barrier", posterpresentation on the 21th Scientific Congress of the Austrian Pharmaceutical Society, Vienna, Austria, 16th-18th April 2009; Abstract in: Sci. Pharm. 77 (1), PO-19 (2009) (http://www.scipharm.at/download.asp?id=450). 27. W.Neuhaus, M. Stessl, E. Strizsik, B. Bennani-Baiti, M. Wirth, J. Mandikova, R. Pawlowitsch, S. Tögel, F. Gabor, H. Viernstein, C.R. Noe:"Functionality of P-glycoprotein in the Blood-Brain Barrier mimicking cell line PBMEC/C1-2", posterpresentation on the 21th Scientific Congress of the Austrian Pharmaceutical Society, Vienna, Austria, 16th-18th April 2009; Abstract in: Sci. Pharm. 77 (1), PO-20 (2009) (http://www.scipharm.at/download.asp?id=451). 28. W. Neuhaus, E. Subileau, C. Chesne, D. Gruber, S. Tögel, W. Klepal, H. Viernstein, C.R. Noe:"A novel Blood-Brain Barrier in vitro Model based on Primary Rat Cells", posterpresentation on the 12th International Symposium for Signalling at the Blood-Brain and Retinal Barriers, London, UK, 9th-11th September 2009. 29. C. Fillafer, M. Prantl, G. Ratzinger, J. Neumann, M.F. Schneider, W. Neuhaus, R. Hofer-Warbinek, M. Wirth, F. Gabor:"Microfluidic system to study the impact of flow on particle-cell interactions", DPhG Doktorandentagung Pichlarn, Austria, 18th-21st November 2009. 30. C. Fillafer, M. Prantl, G. Ratzinger, J. Neumann, M.F. Schneider, W. Neuhaus, R. Hofer-Warbinek, M. Wirth, F. Gabor:"Microfluidics on a chip - impact of flow on the particle-cell interaction", 7th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Valletta, Malta, 8th-11th March 2010. 31. C. Gebhard, E. Strizsik, J. Winkler, W. Neuhaus, M. Marchetti-Deschmann, G. Allmaier, R. Hofer-Warbinek, C.R. Noe:"Differential proteome analysis of BBB endothelia cells in an in vitro model", 4th Central and Eastern European Proteomics Conference, Vienna, Austria, 29th August-1 September 2010. 32. R.R. Bruno, M.A. Schick, W. Neuhaus, N. Roewer, C. Foerster, C. Wunder:"HES 130/0,4 und Gelatine schädigen proximale Nierentubuluszellen in vitro", DEUTSCHER ANÄSTHESIEKONGRESS 2011, Hamburg, Germany, 14th-17th May 2011. 33. W. Neuhaus, M. Burek, C.S. Djuzenova, H. Koepsell, N. Roewer, C.Y. Förster :"NMDA-receptor antagonist MK801 attenuates up-regulation of glucose uptake after oxygen/glucose deprivation in a blood-brain barrier in vitro model", 8th International Symposium on the Biology of Endothelial Cells, ETH Zurich main campus, Zurich, Switzerland, 15th-18th June 2011. 34. W. Neuhaus, M. Burek, C.S. Djuzenova, H. Koepsell, N. Roewer, C.Y. Förster :"Oxygen/glucose deprivation induced upregulation of glucose uptake is inhibitable by a NMDAR antagonist in a blood-brain barrier in vitro model", 9th International Conference on Cerebral Vascular Biology, Leiden, Netherlands, 21th-25th June 2011. 35. A. Sebastiani, D. Yang, C. Luh, H. Koepsell, W. Neuhaus, C. Werner, K. Engelhard, C. Förster, S.C. Thal :"Deficiency in Sodium-Dependent Glucose Transporter 1 has no effect on brain edema formation after traumatic brain injury", EURONEURO 2012, 7th International Update on Interdisciplinary Neursoscience, Vienna, Austria, 16th-18th February 2012. 36. E. Salvador, W. Neuhaus, S. Wais, S. Thal, C. Foerster :"Sodium-dependent glucose transporters expression in the blood brain barrier after injury and its contribution to edema formation", SFB-Meeting, RVZ Würzburg, Germany, 19th-21th April 2012. 37. W. Neuhaus, N. Roewer, C. Foerster, C.:"Interplay of astrocytes and receptor ligands in a mouse blood-brain barrier in vitro model of oxygen/glucose deprivation", abstract for the 4th Transporter-Meeting in Bad Herrenalb (14. Bad Herrenalber Transportertage), Bad Herrenalb, Germany, 14th-16th May 2012. 38. M. Burek, E. Salvador, W. Neuhaus, S. Shityakov, C. Förster:"Generation of an immortalized murine brain microvascular endothelial cell line as an in vitro blood-brain barrier model" posterpresentation at 3rd International Conference Strategies in Tissue Engineering, Würzburg, Germany, 23rd-25th May 2012. 39. W. Neuhaus, A. Neuhoff, M. Burek, N. Roewer, C.Y. Foerster:"The role of astrocytes in a mouse blood-brain barrier in vitro model of oxygen/glucose deprivation" abstract for a talk at the 3rd International Conference Strategies in Tissue Engineering, Würzburg, Germany, 23rd-25th May 2012. 40. W. Neuhaus, M. Burek, N. Roewer, C.Y. Förster:"Inhibition of OGD induced and astrocyte enhanced blood-brain barrier breakdown by specific receptor modulators" , abstract for poster presentaton at the 15th International Symposium Signal transduction in the blood-brain barriers, Potsdam, Germany, 13th-16th September 2012. 41. W. Neuhaus, C.Y. Förster:"Effects of synthetic glucocorticoids on fetal and newborn BBB maturation: implications in adverse health consequences", abstract for a talk at the 15th International Symposium Signal transduction in the blood-brain barriers, Potsdam, Germany, 13th-16th September 2012 42. R.R. Bruno, W. Neuhaus, A. Neuhoff, N. Roewer, M.A. Schick, C. Wunder :"The impact of hydroxyethylstarch 130/0.4 on human proximal tubular cells in vitro", ESICM 2012, 25th Annual Congress of the European Society of Intensive Care Medicine, Lisbon, Portugal, 13th-17th October 2012. 43. W. Neuhaus, M. Burek, C.Y. Foerster: "PPARα agonists stabilize the blood-brain barrier after in vitro stroke by inhibition of MMP and proteasome activity", abstract for a talk at the symposium "Beating the Blood-Brain and other Blood Barriers", Lisbon, Portugal, 6th-8th February 2013. 44. W. Neuhaus, F. Gaiser, N. Schlegel, R. Macrez, D. Vivien, C.Y. Foerster:"NMDAR subunit NR1 is essential for blood-brain barrier damage and cell motility in an in-vitro mouse stroke model", abstract for a talk at the 15th Transporter-Meeting in Bad Herrenalb (15. Bad Herrenalber Transportertage), Bad Herrenalb, Germany, 13th-15th May 2013. 45. E. Salvador, W. Neuhaus, H. Koepsell, C. Foerster:"Sodium-dependent glucose transporter SGLT1 expression in the blood-brain barrier as a result of injury using an in-vitro traumatic brain injury model",abstract for a talk at the 15th Transporter-Meeting in Bad Herrenalb (15. Bad Herrenalber Transportertage), Bad Herrenalb, Germany, 13th-15th May 2013. 46. W. Neuhaus, A. Neuhoff, F. Gaiser, C.Y. Foerster:"Novel therapeutical in-vitro approaches for stroke treatment: The role of the tPA/PAI-1 axis at the blood-brain barrier", abstract and poster at the 16th International Symposium on Signal Transduction in the Blood-Brain Barriers, Sümeg, Hungary, 12th-14th September 2013. 47. R.R. Bruno, W. Neuhaus, N. Roewer, C. Wunder, M.A. Schick:"Die Molekülgröße und die Herstellungsgrundlage (Mais oder Kartoffel) haben keinen Einfluss auf die schädigende Wirkung von Hydroxyethylstärke (HES) auf proximale humane Nierentubulusepithelzellen in-vitro", abstract for a talk at the WAT 2014, Wuerzburg, Germany, 14th-15th February 2014. 48. J. Wollborn, C. Wunder, J. Stix, W. Neuhaus, R. Bruno, S. Flemming, N. Roewer, N. Schlegel, M.A. Schick:"Phosphodiesterase-4-Inhibition vermindert den Leberzellschaden in der systemischen Inflammation in-vitro und in-vivo ohne Einfluss auf die Entzündungsreaktion und die Hämoxygenase-1 (HO-1)", abstract for a talk at the WAT 2014, Wuerzburg, Germany, 14th-15th February 2014. 49. J. Küstermann, D. Bauer, A. Neuhoff, N. Roewer, R.M. Muellenbach, W. Neuhaus:"Hyperoxie induziert eine Steigerung der Barriere in einem humanen in-vitro Modell des Lungenalveolarepithels", abstract for a talk at the WAT 2014, Wuerzburg, Germany, 14th-15th February 2014. 50. W. Neuhaus, S. Mencl, C. Kleinschnitz, C.Y. Foerster:"Antenatal Inflammation Leads to Attenuated Blood-Brain Barrier Permeability after Stroke in Young Adult Mice", abstract and poster at the 16th International Symposium on Signal Transduction at the Blood-Brain and Blood-Retina Barriers, Dublin, Ireland, 11th-13th September 2014. 51. S. Mencl, W. Neuhaus, C. Förster, C. Kleinschnitz:"Antenatal inflammation leads to attenuated blood-brain barrier permeability after stroke in young adult mice", abstract for a poster at the European Stroke Organisation (ESO) Conference, Glasgow, Scotland, 17th-19th April 2015. 52. W. Neuhaus, A. Neuhoff, E.A. Subileau, C. Chesne, C.Y. Foerster:"Effects of oxygen/glucose deprivation: Rat glioma versus primary glial cells", abstract for a talk at the 17th Transporter-Meeting in Bad Herrenalb (17. Bad Herrenalber Transportertage), Bad Herrenalb, Germany, 11th-13th May 2015. 53. A. Appelt-Menzelt, W. Neuhaus, H. Walles, M. Metzger:"Differentiation of human multipotent and pluripotent stem cells to develop a human 3D in vitro blood brain barrier model", abstract for a talk at the 4th International Conference Strategies in Tissue Engineering, Würzburg, Germany, 10th-12th June 2015. 54. W. Neuhaus, F. Gaiser, T. Kraemer, S. Membier, J. Mayrhofer, F. Docagne, R. Macrez, D. Vivien, J. Franz, C. Riethmüller, A. Mahringer, E.A. Subileau, C. Chesne, S. Thal, C.Y. Förster:" An in-vitro blood-brain barrier model for ischemia: Validation and Applicability", abstract for a talk at the 2nd Zing Barriers of the CNS Conference, Oropesa, Spain, 27th-30th September 2015. 55. M.A. Schick, W. Neuhaus, F.Stein, N. Roewer, C. Wunder:"Induktion der Autophagie hebt den HES-induzierten Schaden in humanen proximalen Tubuluszellen der Niere (HK-2) in-vitro auf", abstract for a talk at the WAT 2016, Wuerzburg, Germany, 19th-20th February 2016. Recent publications could be found via this link: AIT publication data base |